KANZHUN LTD - ADR (BZ) Stock Fundamental Analysis

NASDAQ:BZ • US48553T1060

16.24 USD
-0.11 (-0.67%)
At close: Feb 25, 2026
16.24 USD
0 (0%)
After Hours: 2/25/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

Overall BZ gets a fundamental rating of 6 out of 10. We evaluated BZ against 88 industry peers in the Professional Services industry. While BZ has a great health rating, its profitability is only average at the moment. A decent growth rate in combination with a cheap valuation! Better keep an eye on BZ. These ratings could make BZ a good candidate for value investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year BZ was profitable.
  • In the past year BZ had a positive cash flow from operations.
  • In multiple years BZ reported negative net income over the last 5 years.
  • In the past 5 years BZ always reported a positive cash flow from operatings.
BZ Yearly Net Income VS EBIT VS OCF VS FCFBZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B

1.2 Ratios

  • BZ has a better Return On Assets (10.31%) than 81.82% of its industry peers.
  • Looking at the Return On Equity, with a value of 12.92%, BZ is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 9.77%, BZ is in the better half of the industry, outperforming 67.05% of the companies in the same industry.
Industry RankSector Rank
ROA 10.31%
ROE 12.92%
ROIC 9.77%
ROA(3y)5.02%
ROA(5y)-3.62%
ROE(3y)6.59%
ROE(5y)-5.82%
ROIC(3y)N/A
ROIC(5y)N/A
BZ Yearly ROA, ROE, ROICBZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • BZ has a Profit Margin of 31.09%. This is amongst the best in the industry. BZ outperforms 97.73% of its industry peers.
  • BZ has a better Operating Margin (26.94%) than 94.32% of its industry peers.
  • With an excellent Gross Margin value of 84.53%, BZ belongs to the best of the industry, outperforming 95.45% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BZ has remained more or less at the same level.
Industry RankSector Rank
OM 26.94%
PM (TTM) 31.09%
GM 84.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.49%
GM growth 5Y-0.72%
BZ Yearly Profit, Operating, Gross MarginsBZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • BZ has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for BZ has been reduced compared to 1 year ago.
  • Compared to 5 years ago, BZ has more shares outstanding
  • There is no outstanding debt for BZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BZ Yearly Shares OutstandingBZ Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
BZ Yearly Total Debt VS Total AssetsBZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • BZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC1.3
WACC7.54%
BZ Yearly LT Debt VS Equity VS FCFBZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

  • A Current Ratio of 4.18 indicates that BZ has no problem at all paying its short term obligations.
  • BZ has a better Current ratio (4.18) than 93.18% of its industry peers.
  • BZ has a Quick Ratio of 4.18. This indicates that BZ is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 4.18, BZ belongs to the best of the industry, outperforming 93.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.18
Quick Ratio 4.18
BZ Yearly Current Assets VS Current LiabilitesBZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5B 10B 15B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • BZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.62%, which is quite impressive.
  • The Revenue has grown by 12.66% in the past year. This is quite good.
  • Measured over the past years, BZ shows a very strong growth in Revenue. The Revenue has been growing by 49.09% on average per year.
EPS 1Y (TTM)30.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%31.71%
Revenue 1Y (TTM)12.66%
Revenue growth 3Y19.98%
Revenue growth 5Y49.09%
Sales Q2Q%13.17%

3.2 Future

  • BZ is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.51% yearly.
  • Based on estimates for the next years, BZ will show a quite strong growth in Revenue. The Revenue will grow by 11.40% on average per year.
EPS Next Y34.19%
EPS Next 2Y23.01%
EPS Next 3Y21.02%
EPS Next 5Y-2.51%
Revenue Next Year12.58%
Revenue Next 2Y12.88%
Revenue Next 3Y12.99%
Revenue Next 5Y11.4%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BZ Yearly Revenue VS EstimatesBZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
BZ Yearly EPS VS EstimatesBZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 14.76, the valuation of BZ can be described as correct.
  • 67.05% of the companies in the same industry are more expensive than BZ, based on the Price/Earnings ratio.
  • BZ is valuated rather cheaply when we compare the Price/Earnings ratio to 27.05, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 12.37, BZ is valued correctly.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BZ indicates a somewhat cheap valuation: BZ is cheaper than 68.18% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of BZ to the average of the S&P500 Index (28.03), we can say BZ is valued rather cheaply.
Industry RankSector Rank
PE 14.76
Fwd PE 12.37
BZ Price Earnings VS Forward Price EarningsBZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BZ is valued cheaper than 81.82% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, BZ is valued a bit cheaper than the industry average as 76.14% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.44
EV/EBITDA 7.02
BZ Per share dataBZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BZ has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as BZ's earnings are expected to grow with 21.02% in the coming years.
PEG (NY)0.43
PEG (5Y)N/A
EPS Next 2Y23.01%
EPS Next 3Y21.02%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. Dividend

5.1 Amount

  • BZ has a yearly dividend return of 0.84%, which is pretty low.
  • The stock price of BZ dropped by -26.52% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • Compared to an average industry Dividend Yield of 1.67, BZ pays a bit more dividend than its industry peers.
  • With a Dividend Yield of 0.84, BZ pays less dividend than the S&P500 average, which is at 1.80.
Industry RankSector Rank
Dividend Yield 0.84%

5.2 History

  • BZ has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BZ Yearly Dividends per shareBZ Yearly Dividends per shareYearly Dividends per share 2023 2025 0.05 0.1 0.15

5.3 Sustainability

DPN/A
EPS Next 2Y23.01%
EPS Next 3Y21.02%
BZ Yearly Income VS Free CF VS DividendBZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

More info and screens

Find the best dividend stocksShow peers with best dividend

KANZHUN LTD - ADR

NASDAQ:BZ (2/25/2026, 8:00:02 PM)

After market: 16.24 0 (0%)

16.24

-0.11 (-0.67%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)11-18
Earnings (Next)03-09
Inst Owners81.59%
Inst Owner Change-0.65%
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap7.56B
Revenue(TTM)8.01B
Net Income(TTM)2.49B
Analysts84.29
Price Target26.7 (64.41%)
Short Float %6.89%
Short Ratio4.4
Dividend
Industry RankSector Rank
Dividend Yield 0.84%
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.8%
Min EPS beat(2)1.34%
Max EPS beat(2)10.26%
EPS beat(4)3
Avg EPS beat(4)4.5%
Min EPS beat(4)-0.61%
Max EPS beat(4)10.26%
EPS beat(8)7
Avg EPS beat(8)7.78%
EPS beat(12)11
Avg EPS beat(12)266%
EPS beat(16)14
Avg EPS beat(16)207.5%
Revenue beat(2)0
Avg Revenue beat(2)-2.35%
Min Revenue beat(2)-3.08%
Max Revenue beat(2)-1.62%
Revenue beat(4)0
Avg Revenue beat(4)-2.34%
Min Revenue beat(4)-3.08%
Max Revenue beat(4)-1.62%
Revenue beat(8)0
Avg Revenue beat(8)-1.86%
Revenue beat(12)3
Avg Revenue beat(12)-1.32%
Revenue beat(16)4
Avg Revenue beat(16)-1.07%
PT rev (1m)0%
PT rev (3m)2.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.33%
EPS NY rev (1m)0%
EPS NY rev (3m)1.87%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.56%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.12%
Valuation
Industry RankSector Rank
PE 14.76
Fwd PE 12.37
P/S 6.5
P/FCF 12.44
P/OCF 12.44
P/B 2.7
P/tB 2.71
EV/EBITDA 7.02
EPS(TTM)1.1
EY6.77%
EPS(NY)1.31
Fwd EY8.08%
FCF(TTM)1.31
FCFY8.04%
OCF(TTM)1.31
OCFY8.04%
SpS2.5
BVpS6.02
TBVpS5.98
PEG (NY)0.43
PEG (5Y)N/A
Graham Number12.2
Profitability
Industry RankSector Rank
ROA 10.31%
ROE 12.92%
ROCE 11.13%
ROIC 9.77%
ROICexc 1069.68%
ROICexgc 2915.11%
OM 26.94%
PM (TTM) 31.09%
GM 84.53%
FCFM 52.23%
ROA(3y)5.02%
ROA(5y)-3.62%
ROE(3y)6.59%
ROE(5y)-5.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.49%
GM growth 5Y-0.72%
F-Score7
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 157.29%
Profit Quality 168.02%
Current Ratio 4.18
Quick Ratio 4.18
Altman-Z N/A
F-Score7
WACC7.54%
ROIC/WACC1.3
Cap/Depr(3y)260.87%
Cap/Depr(5y)288.66%
Cap/Sales(3y)11.74%
Cap/Sales(5y)9.69%
Profit Quality(3y)326.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%31.71%
EPS Next Y34.19%
EPS Next 2Y23.01%
EPS Next 3Y21.02%
EPS Next 5Y-2.51%
Revenue 1Y (TTM)12.66%
Revenue growth 3Y19.98%
Revenue growth 5Y49.09%
Sales Q2Q%13.17%
Revenue Next Year12.58%
Revenue Next 2Y12.88%
Revenue Next 3Y12.99%
Revenue Next 5Y11.4%
EBIT growth 1Y112.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year81.29%
EBIT Next 3Y33.38%
EBIT Next 5Y21.39%
FCF growth 1Y83.9%
FCF growth 3Y24.82%
FCF growth 5YN/A
OCF growth 1Y83.9%
OCF growth 3Y29.23%
OCF growth 5YN/A

KANZHUN LTD - ADR / BZ FAQ

What is the fundamental rating for BZ stock?

ChartMill assigns a fundamental rating of 6 / 10 to BZ.


Can you provide the valuation status for KANZHUN LTD - ADR?

ChartMill assigns a valuation rating of 7 / 10 to KANZHUN LTD - ADR (BZ). This can be considered as Undervalued.


What is the profitability of BZ stock?

KANZHUN LTD - ADR (BZ) has a profitability rating of 6 / 10.


What is the valuation of KANZHUN LTD - ADR based on its PE and PB ratios?

The Price/Earnings (PE) ratio for KANZHUN LTD - ADR (BZ) is 14.76 and the Price/Book (PB) ratio is 2.7.


How financially healthy is KANZHUN LTD - ADR?

The financial health rating of KANZHUN LTD - ADR (BZ) is 7 / 10.